Similarly, patients with LRRK2 mutations often have prominent prodromal gait deficits, and LRRK2 carriers with synuclein pathology exhibit more cognitive impairment, anxiety, and orthostatic hypotension than those without which will likely have a different prodromal state. Here, LRRK2 is linked to hypotensive disorder.